Tzield is a medicine that contains the active substance teplizumab. It belongs to a group of medicines called ‘monoclonal antibodies'.^1,2

Tzield is a protein that recognises and sticks to a target. The target is a substance called CD3 that is found on a type of white blood cell – called ‘T lymphocytes’.^1,2

When Tzield sticks to T lymphocytes it can help to slow down the attack on beta cells.^2,3

By slowing down the autoimmune attack on beta cells, your pancreas can keep producing insulin on its own for
a little longer.^2,3

You may be interested to find out…

Tzield is a medicine used to delay the start of Stage 3 Type 1 diabetes. This condition happens when the body cannot make enough insulin on its own and may need insulin injections. This medicine is used in adults and children aged 8 years and older who have Stage 2 Type 1 diabetes.¹

If you have any questions on how Tzield works or about your treatment with Tzield, ask your doctor.